Can biventricular pacing (Biventricular Pacing) reduce ventricular tachycardia (VT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Biventricular Pacing for Reducing Ventricular Tachycardia

Biventricular pacing can significantly reduce the incidence of ventricular tachycardia (VT) in selected patients with heart failure, particularly those with left ventricular dysfunction, intraventricular conduction delay, and QRS prolongation.

Mechanism and Evidence

Biventricular pacing (cardiac resynchronization therapy or CRT) works by synchronizing the contraction of the left ventricle, which can:

  • Improve cardiac hemodynamics and pump function 1
  • Increase left ventricular ejection fraction 1
  • Reduce mechanical dyssynchrony that may trigger arrhythmias 1
  • Reverse adverse cardiac remodeling 1

The Ventak CHF trial demonstrated that patients receiving biventricular pacing had significantly fewer episodes requiring tachycardia therapy compared to periods without pacing (16% vs 34%, p=0.035) 2. This suggests that CRT not only improves heart failure symptoms but also reduces arrhythmic events.

Patient Selection for CRT to Reduce VT

The strongest evidence supports CRT in patients with:

  1. Heart failure with reduced ejection fraction:

    • LVEF ≤35% 1
    • NYHA functional class III-IV symptoms 1
    • QRS duration ≥120 ms (strongest evidence for ≥150 ms) 1
    • Left bundle branch block pattern 1
  2. Patients with conventional pacing indications:

    • Those requiring high percentage of ventricular pacing
    • Patients with existing right ventricular pacing who have developed LV dysfunction 1

Implementation Considerations

When implementing biventricular pacing to reduce VT:

  • Lead placement is critical: Optimal positioning of the left ventricular lead is essential for maximizing resynchronization and reducing arrhythmic events
  • Avoid right ventricular pacing in heart failure patients with LV dysfunction, as it can induce dyssynchrony 1
  • Consider CRT-D (with defibrillator) rather than CRT-P (pacemaker only) for patients with high risk of sudden cardiac death 1
  • Beta-blocker therapy can be better tolerated with CRT, allowing for improved medical management 1

Special Situations

Refractory VT

For patients with refractory VT despite standard CRT:

  • Consider dual-site left ventricular pacing plus biventricular pacing as demonstrated in case reports 3
  • This approach may provide an alternative strategy when conventional treatments fail

VT Triggered by CRT

In rare cases, CRT may actually trigger VT 4. If this occurs:

  • Catheter ablation may be necessary to target the arrhythmogenic focus
  • After successful ablation, CRT can often be continued without recurrence of VT

Limitations and Caveats

  • Not all patients respond to CRT (non-responder rate ranges from 20-40%) 1
  • Patients with permanent atrial fibrillation may have suboptimal benefit unless AV node ablation is performed to ensure adequate biventricular capture 1
  • Complications of CRT implantation include lead dislodgement, infection, and coronary sinus dissection 5
  • The value of biventricular pacing without additional ICD support for the reduction of sudden death remains controversial 1

In conclusion, biventricular pacing represents an important therapeutic option for reducing ventricular tachycardia in appropriately selected patients with heart failure, particularly those with ventricular dyssynchrony evidenced by QRS prolongation and left bundle branch block pattern.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Transvenous dual site left ventricular pacing plus biventricular pacing for the management of refractory ventricular tachycardia.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.